The Obesity Pricing Paradigm Gets Even More Complex With Novo’s $199 Wegovy Offer
Shares:
Reading Bob Herman’s new STAT piece about the newest PBM tactic -- something called “rebate credits” -- is kind of tough sledding. The source materials aren’t made available, so his
It’s a big day for PDABs. Buckle up. *** The biggest news is probably Amgen’s suit against the state of Colorado that makes the case that the prescription drug affordability
Programming Note: The plan is for Cost Curve to be off on Monday, in part because it’s Patriots’ Day and in part because, jeez, I think we all need a